Enveric Biosciences, Inc. — Form D

Enveric Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-02. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Business Services.

Offering

Issuer

Officers, directors & promoters (58)

Showing 25 of 58 people.

NameRoleLocation
Venkatraman BalakrishnanDirectorSuwanee, GA
Jeffrey EberweinDirectorSuwanee, GA
Robert PearseDirectorSuwanee, GA
David JohnsonDirectorGreenwood Village, CO
David JohnsonExecutive OfficerGreenwood Village, CO
Sheila W DeWittDirectorCambridge, MA
George W KeglerDirectorCambridge, MA
Kevin M CoveneyExecutive OfficerCambridge, MA
Marcus W SchabackerDirectorCambridge, MA
Frank W PasqualoneDirectorCambridge, MA
Michael D WebbDirectorCambridge, MA
Joseph E TuckerDirectorCambridge, MA
Joseph E TuckerExecutive OfficerCambridge, MA
David LuciDirectorJersey City, NJ
VIRAJ PATELExecutive OfficerSeattle, WA
Dimitrios AngelisDirectorDenver, CO
Brent KeltonExecutive OfficerAustin, TX
Joseph TuckerDirectorNaples, FL
Joseph TuckerExecutive OfficerNaples, FL
Bob DagherExecutive OfficerNaples, FL
Marcus SchabackerDirectorNaples, FL
Douglas LindDirectorNaples, FL
Frank PasqualoneDirectorCambridge, MA
Frank PasqualoneRelated PersonCambridge, MA
Peter FacchiniExecutive OfficerNaples, FL

Other filings by this issuer (9)

FiledFormOfferingSold
2026-05-04D$5.0M$5.0M
2026-02-11D$1.5M$1.5M
2025-12-23D$107K$107K
2025-10-03D
2023-04-19D/A$12.8M$12.8M
2022-08-05D$8.6M$8.6M
2021-02-24D$8.4M
2021-01-20D$8.2M
2018-08-28D/A$6.6M$6.6M

More